Active Ingredient: NALOXONE HYDROCHLORIDE
Proprietary Name: ZIMHI
Dosage Form; Route of Administration: SOLUTION; INTRAMUSCULAR, SUBCUTANEOUS
Strength: 5MG/0.5ML (5MG/0.5ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N212854
Product Number: 001
Approval Date: Oct 15, 2021
Applicant Holder Full Name: ADAMIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
